NYSE:PMTobacco
Philip Morris International (PM) Gets FDA Backing For ZYN On Fair Value Stays In Focus
The U.S. Food and Drug Administration has granted Philip Morris International (PM) permission to market its ZYN nicotine pouches as modified risk tobacco products, marking the first such designation for smoke free pouches in the U.S.
See our latest analysis for Philip Morris International.
For investors, this FDA milestone comes during a strong period for Philip Morris International, with a 19.95% 90 day share price return and a 143.58% five year total shareholder return. This suggests that...